Human HCAR1 Virus-Like Particles

HCAR1 (hydroxycarboxylic acid receptor 1), also known as GPR81, is a G protein-coupled receptor (GPCR) primarily expressed in adipose tissue, liver, and the central nervous system. It plays a key role in metabolic regulation by binding to endogenous ligands, such as lactate, thereby modulating lipolysis and energy homeostasis. Activation of HCAR1 has been associated with anti-inflammatory effects, insulin sensitivity, and potential therapeutic applications in metabolic disorders, including obesity and type 2 diabetes. Due to its physiological significance, HCAR1 has become a target for drug development and biomedical research.

Human HCAR1 virus-like particles (VLPs) are non-infectious nanostructures designed to mimic the membrane-bound form of the native HCAR1 receptor but lack viral genetic material. These VLPs are typically produced by expressing HCAR1 and viral structural proteins, such as envelope or capsid proteins, in recombinant systems, such as mammalian, insect, or yeast cells. The self-assembly properties of VLPs ensure proper folding and post-translational modification of HCAR1, making them excellent tools for studying receptor-ligand interactions, antibody development, and vaccine design. HCAR1 VLPs offer advantages over traditional soluble receptors because they preserve the native conformation and membrane environment of HCAR1, enabling more accurate biochemical and immunological studies. Furthermore, they hold promise as delivery vehicles for targeted therapies or as immunogens for generating HCAR1-specific antibodies for diagnostic and therapeutic applications.